Since inflammation and oxidative stress are key drivers of adverse cardiac remodeling, we assessed the gene expression levels of ANP and BNP, well-established markers of myocardial stress that are upregulated in heart failure and myocardial infarction and also used as indicators of ventricular hypertrophy [73,74]. The gene discussed is NPPA; the disease is cardiac hypertrophy.